Autism is a collection of behavioral symptoms characterized by dysfunction in social interaction and communication in affected children. It is typically associated with restrictive, repetitive, and stereotypic behavior and manifests within the first 3 years of life. The cause of this disorder is not known. Over the past decade, a significant upswing in research has occurred to examine the biologic basis of autism. Recent clinical studies have revealed a high prevalence of gastrointestinal symptoms, inflammation, and dysfunction in children with autism. Mild to moderate degrees of inflammation were found in both the upper and lower intestinal tract. In addition, decreased sulfation capacity of the liver, pathologic intestinal permeability, increased secretory response to intravenous secretin injection, and decreased digestive enzyme activities were reported in many children with autism. Treatment of digestive problems appears to have positive effects on autistic behavior. These new observations represent only a piece of the unsolved autism "puzzle" and should stimulate more research into the brain-gut connection.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
References and Recommended Reading
Bertrand J, Mars A, Boyle C, et al.: Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 2001, 108:1155–1161.
Goodwin MS, Cowen MA, Goodwin TC: Malabsorption and cerebral dysfunction: a multivariate and comparative study of autistic children. J Autism Child Schizophr 1971, 1:48–62.
Walker-Smith J, Andrews J: Alpha-1-antitrypsin, autism, and coeliac disease. Lancet 1972, 2:8830150884.
Melmed RD, Schneider C, Fabes RA, et al.: Metabolic markers and gastrointestinal symptoms in children with autism and related disorders. J Pediatr Gastroenterol Nutr 2000, 31(suppl 2):S31-S32.
Lightdale JR, Siegel B, Heyman MB: Gastrointestinal symptoms in autistic children. Clin Perspect Gastroenterol 2001, 31(suppl 2):56–58.
Dalrymple NJ, Ruble LA: Toilet training and behaviors of people with autism: parent views. J Autism Dev Disord 1992, 22:265–275.
Ghaem M, Armstrong KL, Trocki O, et al.: The sleep patterns of infants and young children with gastro-oesophageal reflux. J Paediatr Child Health 1998, 34:160–163.
Wakefield AJ, Anthony A, Murch SH, et al.: Enterocolitis in children with developmental disorders. Am J Gastroenterol 2000, 95:2285–2295. This study was comprised of 60 children with developmental delay including 50 children with autism. Ileal LNH was present in 93% and colonic LNH in 30% of the children. The histologic examination revealed reactive follicular hyperplasia in 88.5%, and chronic colitis was identified in 88% of the developmentally delayed children.
Horvath K, Papadimitriou JC, Rabsztyn A, et al.: Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 1999, 135:559–563. This paper describes the gastrointestinal abnormalities found in 36 children with autism who underwent upper gastrointestinal endoscopy for the evaluation of chronic diarrhea, gaseousness, abdominal discomfort, and distention. Grade 1 or 2 reflux esophagitis was found in 25, chronic gastritis in 15, and chronic duodenitis in 24. An increase in the number of Paneth cells was observed. Low intestinal carbohydrate digestive enzyme activity was reported in 21 children, and 27 had increased pancreatobiliary fluid output after IV secretin administration.
Furlano RI, Anthony A, Day R, et al.: Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 2001, 138:366–372. These authors report the findings of immunohistochemical studies in 21 children with autism and four control groups. They describe lymphocytic colitis, basement membrane thickening, increased mucosal gamma delta cell and CD8+ density, and intraepithelial lymphocyte numbers. The epithelium was HLA-DR-negative, which is suggestive of a Th-2 response.
D‘Eufemia P, Celli M, Finocchiaro R, et al.: Abnormal intestinal permeability in children with autism. Acta Paediatr 1996, 85:1076–1079.
Horvath K, Zielke H, Collins J, et al.: Secretin improves intestinal permeability in autistic children. J Pediatr Gastroenterol Nutr 2000, 31(suppl 2):S30-S31.
Sandler RH, Finegold SM, Bolte ER, et al.: Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000, 15:429–435. This report is from an open clinical trial with oral vancomycin in children with autistic behavior. Behavioral improvement was noted in eight of 10 children studied. The behavioral gains disappeared after the discontinuation of therapy. These results indicate that a possible gut flora-brain connection warrants further investigation.
Lenzen R, Alpini G, Tavoloni N: Secretin stimulates bile ductular secretory activity through the cAMP system. Am J Physiol 1992, 263:G527-G532.
Alberti A, Pirrone P, Elia M, et al.: Sulphation deficit in ‘low-functioning’ autistic children: a pilot study. Biol Psychiatry 1999, 46:420–424. This study examined the liver sulfation capacity in 20 "low-functioning" autistic children and in an age-matched control group by using paracetamol. The group of autistic subjects had significantly lower results than the control group (P < 0.00002). The authors concluded that the inability to metabolize certain compounds effectively, particularly phenolic amines — which are toxic for the CNS — could exacerbate the wide spectrum of autistic behavior.
O‘Reilly B, Waring R: Enzyme and sulfur oxidation deficiencies in autistic children with known food/chemical intolerances. J Orthomolec Med 1993, 4:198–200.
Waring RH, Ngong JM, Klovrza L, et al.: Biochemical parameters in autistic children. Dev Brain Dysfunction 1997, 1:40–43.
Pavone L, Fiumara E, Bottaro G, et al.: Autism and celiac disease: failure to validate the hypothesis that a link might exist. Biol Psychiatry 1997, 42:72–75.
McCarthy DM, Coleman M: Response of intestinal mucosa to gluten challenge in autistic subjects. Lancet 1979, 2:877–878.
Huebner FR, Lieberman KW, Rubino RP, Wall JS: Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates. Peptides 1984, 5:1139–1147.
Brantl V: Novel opioid peptides derived from human beta-casein: human beta-casomorphins. Eur J Pharmacol 1984, 106:213–214.
Graf L, Horvath K, Walcz E, et al.: Effect of two synthetic alpha-gliadin peptides on lymphocytes in celiac disease: identification of a novel class of opioid receptors. Neuropeptides 1987, 9:113–122.
Brantl V, Teschemacher H, Henschen A, Lottspeich F: Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone. Hoppe-Seylers Zeitschrift Fur Physiologische Chemie 1979, 360:1211–1216.
Singh M, Rosen CL, Chang KJ, Haddad GG: Plasma betacasomorphin-7 immunoreactive peptide increases after milk intake in newborn but not in adult dogs. Pediatr Res 1989, 26:34–38.
Shattock P, Kennedy A, Rowell F, Berney T: Role of neuropeptides in autism and their relationship with classical neurotransmitters. Brain Dysfunction 1990, 3:328–345.
Shattock P, Lowdon G: Proteins, peptides and autism. Part 2: Implication for the education and care of people with autism. Brain Dysfunction 1991, 4:323–334.
Reichelt K, Ekrem J, Scott H: Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion. J Appl Nutr 1990, 42:1–12.
Zagon I, McLaughlin P: Endogenous opioid systems regulate cell proliferation in the developing rat brain. Brain Res 1987, 412:68–72.
Bouvard MP, Leboyer M, Launay JM, et al.: Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study. Psychiatry Res 1995, 58:191–201.
Knivsberg AM, Reichelt KL, Nodland M, Hoien T: Autistic syndromes and diet: a follow-up study. Scand J Educ Res 1995, 39:223–236.
Lucarelli S, Frediani T, Zingoni AM, et al.: Food allergy and infantile autism. Panminerva Med 1995, 37:137–141.
Halsey NA, Hyman SL: Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12–13, 2000. Pediatrics 2001, 107:E84.
Gershon MD: The Second Brain: A Groundbreaking New Understanding of Nervous Disorders of the Stomach and Intestine. New York: HarperPerennial; 1998.
About this article
Cite this article
Horvath, K., Perman, J.A. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 4, 251–258 (2002). https://doi.org/10.1007/s11894-002-0071-6
- Autistic Spectrum Disorder
- Celiac Disease
- Food Allergy
- Gastrointestinal Symptom